<DOC>
	<DOCNO>NCT02237365</DOCNO>
	<brief_summary>Tuberculous meningitis severe brain infection often cause disability death even treat best available treatment . Aspirin type anti-inflammation drug reduce inflammatory response brain patient tuberculous meningitis , therefore may decrease severe outcome . This study compare use aspirin ( 2 different dos ) versus placebo additional therapy standard treatment see aspirin safe helpful reduce disability death tuberculous meningitis . Patients treat aspirin placebo 60 day follow standard treatment 8 month .</brief_summary>
	<brief_title>A Pilot Study Adjunctive Aspirin Treatment HIV Negative Adults With Tuberculous Meningitis</brief_title>
	<detailed_description>The study parallel group , double blind , randomise , placebo control trial 60 day treatment placebo vs. 81mg daily dose vs. 1000mg daily dose aspirin treatment HIV-uninfected adult tuberculous meningitis . All patient receive standard anti-tuberculous chemotherapy adjunctive dexamethasone , accord Viet Nam National Tuberculosis Programme guideline . Participants stratify Medical Research Council UK disease severity grade , randomize enrollment one three study arm ( 1:1:1 ratio ) . Patients admitted hospital least first 14 day study treatment enable real-time active surveillance adverse event discharge accord clinical care continue monitoring . A schedule clinical laboratory monitoring include lumbar puncture , pharmacokinetic assessment peripheral blood monocyte/macrophage antimicrobial activity , clinical assessment , brain magnetic resonance imaging ( MRI ) neurological assessment manage patient safety capture study outcome .</detailed_description>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Tuberculosis , Meningeal</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Male female , age 18 year . Suspected TBM antituberculosis chemotherapy either plan start Less 3 day antituberculosis chemotherapy take current infection Patient representative ( patient unable ) willing able give inform consent participation study . HIV infection ( negative rapid test Elisa test require ) Unlikely , reason , able MRI brain scan within 5 day ( 120 hour ) randomisation Known suspect infection multidrug resistant tuberculosis ( resistant least isoniazid rifampicin ) Unable take isoniazid , rifampicin , pyrazinamide recommend dos reason History diagnose peptic ulceration gastrointestinal bleeding Active gastrointestinal bleeding suspect Taken &gt; 1 dose aspirin ( dose ) nonsteroidal antiinflammatory drug reason within 2 week screen Aspirin consider mandatory reason attend physician Aspirin consider contraindicated reason attend physician Pregnancy breast feeding ( negative urine pregnancy test female childbearing age ) Dexamethasone consider contraindicated reason attend physician Any significant disease disorder , opinion investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>neurological disability</keyword>
	<keyword>tuberculous meningitis ( TBM )</keyword>
	<keyword>safety</keyword>
	<keyword>aspirin</keyword>
	<keyword>efficacy</keyword>
</DOC>